ZDHHC9 as a Potential Biomarker for Prognostic Evaluation and Diagnostic Identification in BRCA, CESC, HNSC, and KIRP Tumors

Qunlong Liu; Wenxia Li; Ming Xie; Ming Yang; Mei Xu; Lei Yang; Mengru Sun; Yanna Peng; Li Gao; Qunlong Liu; Wenxia Li; Ming Xie; Ming Yang; Mei Xu; Lei Yang; Mengru Sun; Yanna Peng; Li Gao

doi:10.1155/ecc/2641908

2025 Volume 2025

Article Contents

Next Previous

RESEARCH ARTICLE Open Access

ZDHHC9 as a Potential Biomarker for Prognostic Evaluation and Diagnostic Identification in BRCA, CESC, HNSC, and KIRP Tumors

More Information

Published online: 20 March 2025
European Journal of Cancer Care 2025, Article number: 10.1155/ecc/2641908 (2025) | Cite this article

Rights and permissions
Copyright: © 2025 by the author(s). Exclusive Licensee Maximum Academic Press, Fayetteville, GA. This article is an open access article distributed under Creative Commons Attribution License (CC BY 4.0), visit https://creativecommons.org/licenses/by/4.0/.

About this article

Cite this article

Qunlong Liu, Wenxia Li, Ming Xie, Ming Yang, Mei Xu, Lei Yang, Mengru Sun, Yanna Peng, Li Gao. 2025. ZDHHC9 as a Potential Biomarker for Prognostic Evaluation and Diagnostic Identification in BRCA, CESC, HNSC, and KIRP Tumors. European Journal of Cancer Care. 2025:8 doi: 10.1155/ecc/2641908

Qunlong Liu, Wenxia Li, Ming Xie, Ming Yang, Mei Xu, Lei Yang, Mengru Sun, Yanna Peng, Li Gao. 2025. ZDHHC9 as a Potential Biomarker for Prognostic Evaluation and Diagnostic Identification in BRCA, CESC, HNSC, and KIRP Tumors. European Journal of Cancer Care. 2025:8 doi: 10.1155/ecc/2641908

Download PDF

Article Metrics

Article views(18) PDF downloads(15)